Articles from Investor's Business Daily

TikTok shut down U.S. operations Saturday night, complying with a U.S. law even as Donald Trump said a reprieve is "likely."

By merging with TikTok's U.S. arm, Perplexity could be a stronger search rival to Google.

The president-elect's businesses hold 80% of the digital asset's market cap.

Broadcom is one of three AI plays on this weekend's watchlist.

Argan stock hit a record high Friday. Argan is a leader in the hot construction sector with a perfect 99 Composite Rating.

The most traveled road to peace of mind comes when you find your purpose in life. Anything great is usually driven by having a purpose.

In 1995, Mark Allen was struggling to make history. At age 37, he sought to become the oldest person to win the Ironman triathlon.

Marex stock and Clearwater Analytics are new stocks on the IBD Sector Leaders screen. Seventeen other stocks joined IBD watchlists today.

On Monday, TD SYNNEX stock had its Relative Strength (RS) Rating upgraded to 86, up from 70 a day earlier.

On Friday, metrology equipment maker Camtek stock had its Relative Strength (RS) Rating upgraded to 83, up from 74 a day earlier.

One key metric to look for in a stock is an 80-plus RS Rating. Nextracker stock cleared that benchmark Friday, jumping to 80 Friday.

Viking Cruises, Royal Caribbean receive price hikes as cruise booking demand stays strong. VIK breaks out, cruise lines retake key averages.

The TikTok ban got an OK from the Supreme Court. But Meta stock and Snap were lower Friday amid last-ditch efforts to save the competing app.

Construction stocks are on the move. But a wary mood is evident as Donald Trump returns to Washington.

Many stocks flashed buy signals as the major indexes rose to or above key levels.

Salesforce stock won an upgrade to buy from TD Cowen, which pointed to momentum for its new artificial intelligence platform.

Vistra stock dropped early Friday after news reports of a fire at a major energy storage lithium-ion battery facility.

The price negotiations will take place in 2025 and go into effect in 2027 for a new list of 15 drugs.

Quantum computing is still early, experts say. Finding early stock winners is easier than crunching calculations.

SLB reported earnings Friday.

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns.

President-elect Donald Trump plans a wave of executive orders for his first day back in office. Some could shape bitcoin, crypto regulations.

The cybersecurity leader is back near highs. Raymond James's David Cox isn't sold.

Netflix stock is down over 4% so far in 2025. Investors are hoping the streaming video leader can get back on track with its Q4 report.

Berkshire Hathaway took a 'Rip Van Winkle' approach to Amex while selling other stocks. And it has paid off.

The company is facing numerous headline risks. But not all of them are legitimate, says one analyst.

The company is working to launch its COPD treatment more broadly. The drug is a non-steroidal nebulizer.

Life Time is set to break out to record highs on its preliminary Q4 results, 2025 outlook. Planet Fitness scored a breakout earlier this week.

Bank of America, Morgan Stanley earnings more than double for Q4. BAC stock and MS shares are closing in on buy points.

The Trump administration is reportedly considering how to prevent a TikTok ban that goes into effect Sunday. Meta stock fell.

The ex-Cisco chief is bullish on quantum computing long term.

The Dow giant earnings beat Q4 views, but revenue missed and medical costs ran high.

Taiwan Semiconductor Manufacturing beat analyst estimates for the fourth quarter, thanks to strong sales of AI chips. TSM stock surged.

One key metric to look for in a stock is an 80-plus Relative Strength Rating. BeiGene stock just hit that mark, with a jump to 84 Wednesday.

The TikTok ban will take effect Sunday. Here's what could save the app and how Meta stock, Google and others could benefit from the ban.

In a welcome move, GitLab stock saw its Relative Strength Rating rise o 79 on Wednesday, up from 69 a day earlier.

Spotify stock approached a buy point after three Wall Street analysts raised their price targets on the streaming music leader.

The news media is too focused on small moves in Nvidia stock when they should be considering longer-term trends, a Wall Street analyst says.

Many analysts think the zero-fee stock and crypto trading app isn't done yet. It quadrupled in past year.

The company expects sales to grow 12% to 13% annually in the long term.

William Blair initiated coverage of Affirm stock and SoFi with out-perform ratings viewing them as share gainers in the consumer financing market.

A Meta stock analyst said the company's generative AI push could help drive new revenue from WhatsApp through chatbots.

The company cut its fourth-quarter guidance by 5%. But there's still a lot happening for Lilly.

The company also forecasts 13% to 16% procedure growth in 2025.

Quantum computing stocks led by D-Wave Quantum popped on Wednesday continuing their rollercoaster ride in 2025.

Donald Trump returns to the White House on Jan. 20 and Trump Media stock is galloping higher as it looks to shed its meme stock reputation.

Markets expect that core inflation rose more slowly in December.

Markel Group has posted outstanding results in three of the last four quarters including a 2,010% increase in earnings last quarter.

BridgeBio Pharma stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 to 87.

American Electric Power stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 67 to 72.

Spotify Technology stock on Tuesday received a price-target hike from a Wall Street analyst who rates the music streamer a "best idea."

Big banks kick off Q4 results with Goldman Sachs, JPMorgan Chase, Wells Fargo, BlackRock reporting. Some names are basing.

The debate over quantum computing raged for a second week as SAP's CEO argued that the technology can have an impact in three to four years.

Eli Lilly stock fell on lowered Q4 guidance amid slower-than-expected sales for its Zepbound and Mounjaro weight loss drugs.

The producer price index showed flat core prices last month.

With the TikTok ban looming, Chinese officials are reportedly weighing whether to allow a sale of the app to Elon Musk.

Teladoc Health, Amazon announce a new health care partnership to discover and enroll in benefits programs. TDOC stock surges.

United Rentals announced early Tuesday it has agreed to acquire H&E Equipment Services for $4.8 billion.

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.

Fed chief Jerome Powell has said "policy uncertainty" clouds the rate outlook.

President-elect Trump's advisers reportedly are studying plans to phase-in increases.

Apple stock continued its downward trajectory Monday on the latest reports of soft iPhone sales and brutal criticism by Mark Zuckerberg.

On Monday, SpringWorks Therapeutics stock hit a key technical milestone, seeing its Relative Strength Rating jump to 86.

Some companies saw their shares skyrocket on preliminary reports, but others took hits.

In a welcome move, Coterra Energy stock saw its Relative Strength Rating to 74 Monday, up from 65 a day earlier.

Startup OpenAI on Monday joined its biggest investor, Microsoft, in proposing AI infrastructure projects.

Analysts with Needham say Instacart stock is a buy, as the company is growing strong despite competition from Uber, Amazon and DoorDash.

Quantum computing stocks fell again after Mark Zuckerberg joined Nvidia's CEO in claiming the technology is far off from commercial usage.

The company also had a setback for its CMV vaccine.

Urban Outfitters and American Eagle also reported holiday sales.

Nvidia stock fell Monday after the White House announced new export restrictions on artificial intelligence processors.

Markets now see little chance of more than one Fed rate cut in 2025.

The company is also facing off with biosimilars for standard Eylea and competition with Roche.

The deal values the smaller biotech company at a 39% premium to last week's closing price.

Morgan Stanley analyst Adam Jonas hiked his Tesla price target Monday.